Maria José Martinez-Zapata

Summary

Publications

  1. doi request reprint Homocysteine-lowering interventions for preventing cardiovascular events
    Arturo J Martí-Carvajal
    Facultad de Ciencias de la Salud Eugenio Espejo, Universidad Tecnológica Equinoccial, Quito, Ecuador
    Cochrane Database Syst Rev 1:CD006612. 2013
  2. doi request reprint Antibiotics for treating acute chest syndrome in people with sickle cell disease
    Arturo J Martí-Carvajal
    Facultad de Ciencias de la Salud Eugenio Espejo, Universidad Tecnológica Equinoccial, Quito, Ecuador
    Cochrane Database Syst Rev 1:CD006110. 2013
  3. doi request reprint Antibiotics for treating osteomyelitis in people with sickle cell disease
    Arturo J Martí-Carvajal
    Facultad de Ciencias de la Salud Eugenio Espejo, Universidad Tecnológica Equinoccial, Quito, Ecuador
    Cochrane Database Syst Rev 12:CD007175. 2012
  4. doi request reprint Human recombinant protein C for severe sepsis and septic shock in adult and paediatric patients
    Arturo J Martí-Carvajal
    Facultad de Ciencias de la Salud Eugenio Espejo, Universidad Tecnológica Equinoccial, Quito, Ecuador
    Cochrane Database Syst Rev 12:CD004388. 2012
  5. doi request reprint Interventions for treating leg ulcers in people with sickle cell disease
    Arturo J Martí-Carvajal
    Facultad de Ciencias de la Salud Eugenio Espejo, Universidad Tecnológica Equinoccial, Quito, Ecuador
    Cochrane Database Syst Rev 11:CD008394. 2012
  6. doi request reprint Human recombinant activated factor VII for upper gastrointestinal bleeding in patients with liver diseases
    Arturo J Martí-Carvajal
    Universidad de Carabobo and Iberoamerican Cochrane Network, Valencia, Edo Carabobo, Venezuela
    Cochrane Database Syst Rev 3:CD004887. 2012
  7. doi request reprint Antibiotics for treating community acquired pneumonia in people with sickle cell disease
    Arturo J Martí-Carvajal
    Facultad de Ciencias de la Salud Eugenio Espejo, Universidad Tecnológica Equinoccial, Quito, Ecuador
    Cochrane Database Syst Rev 10:CD005598. 2012
  8. doi request reprint Antifibrinolytic amino acids for upper gastrointestinal bleeding in patients with acute or chronic liver disease
    Arturo J Martí-Carvajal
    Facultad de Ciencias de la Salud Eugenio Espejo, Universidad Tecnológica Equinoccial, Quito, Ecuador
    Cochrane Database Syst Rev 9:CD006007. 2012
  9. doi request reprint Vitamin K for upper gastrointestinal bleeding in patients with acute or chronic liver diseases
    Arturo J Martí-Carvajal
    Facultad de Ciencias de la Salud Eugenio Espejo, Universidad Tecnológica Equinoccial, Quito, Ecuador
    Cochrane Database Syst Rev 9:CD004792. 2012
  10. doi request reprint Treatment for avascular necrosis of bone in people with sickle cell disease
    Arturo J Martí-Carvajal
    Universidad de Carabobo and Iberoamerican Cochrane Network, Valencia, Venezuela
    Cochrane Database Syst Rev 5:CD004344. 2012

Collaborators

  • Arturo J Martí-Carvajal
  • Ivan Solà
  • Dimitrios Lathyris
  • Lucieni O Conterno
  • Jennifer M Knight-Madden
  • Despoina Elvira Karakitsiou
  • Andres Felipe Cardona
  • Luis H Agreda-Pérez
  • Daniel Simancas-Racines
  • Pedro I Martí-Carvajal
  • Georgia Salanti
  • Christian Gluud

Detail Information

Publications11

  1. doi request reprint Homocysteine-lowering interventions for preventing cardiovascular events
    Arturo J Martí-Carvajal
    Facultad de Ciencias de la Salud Eugenio Espejo, Universidad Tecnológica Equinoccial, Quito, Ecuador
    Cochrane Database Syst Rev 1:CD006612. 2013
    ..A postulated risk factor is elevated circulating total homocysteine levels, which are associated with cardiovascular events. This is an update of a review previously published in 2009...
  2. doi request reprint Antibiotics for treating acute chest syndrome in people with sickle cell disease
    Arturo J Martí-Carvajal
    Facultad de Ciencias de la Salud Eugenio Espejo, Universidad Tecnológica Equinoccial, Quito, Ecuador
    Cochrane Database Syst Rev 1:CD006110. 2013
    ..Thus, there is a need to identify the efficacy and safety of different antibiotic treatment approaches for people with sickle cell disease suffering from acute chest syndrome...
  3. doi request reprint Antibiotics for treating osteomyelitis in people with sickle cell disease
    Arturo J Martí-Carvajal
    Facultad de Ciencias de la Salud Eugenio Espejo, Universidad Tecnológica Equinoccial, Quito, Ecuador
    Cochrane Database Syst Rev 12:CD007175. 2012
    ..Thus, there is a need to identify the efficacy and safety of different antibiotic treatment approaches for people with sickle cell disease suffering from osteomyelitis...
  4. doi request reprint Human recombinant protein C for severe sepsis and septic shock in adult and paediatric patients
    Arturo J Martí-Carvajal
    Facultad de Ciencias de la Salud Eugenio Espejo, Universidad Tecnológica Equinoccial, Quito, Ecuador
    Cochrane Database Syst Rev 12:CD004388. 2012
    ..Human recombinant activated protein C (APC) has been introduced to reduce the high risk of death associated with severe sepsis or septic shock. This systematic review is an update of a Cochrane review originally published in 2007...
  5. doi request reprint Interventions for treating leg ulcers in people with sickle cell disease
    Arturo J Martí-Carvajal
    Facultad de Ciencias de la Salud Eugenio Espejo, Universidad Tecnológica Equinoccial, Quito, Ecuador
    Cochrane Database Syst Rev 11:CD008394. 2012
    ..Many treatment options are available to the healthcare professional, although it is uncertain which treatments have been assessed for effectiveness in people with sickle cell disease...
  6. doi request reprint Human recombinant activated factor VII for upper gastrointestinal bleeding in patients with liver diseases
    Arturo J Martí-Carvajal
    Universidad de Carabobo and Iberoamerican Cochrane Network, Valencia, Edo Carabobo, Venezuela
    Cochrane Database Syst Rev 3:CD004887. 2012
    ..Mortality from upper gastrointestinal bleeding in patients with liver disease is high. Recombinant human activated factor VII (rHuFVIIa) has been suggested for patients with liver disease and upper gastrointestinal bleeding...
  7. doi request reprint Antibiotics for treating community acquired pneumonia in people with sickle cell disease
    Arturo J Martí-Carvajal
    Facultad de Ciencias de la Salud Eugenio Espejo, Universidad Tecnológica Equinoccial, Quito, Ecuador
    Cochrane Database Syst Rev 10:CD005598. 2012
    ..Thus, there is a need to identify the efficacy and safety of different antibiotic treatment approaches for people with sickle cell disease suffering from community-acquired pneumonia...
  8. doi request reprint Antifibrinolytic amino acids for upper gastrointestinal bleeding in patients with acute or chronic liver disease
    Arturo J Martí-Carvajal
    Facultad de Ciencias de la Salud Eugenio Espejo, Universidad Tecnológica Equinoccial, Quito, Ecuador
    Cochrane Database Syst Rev 9:CD006007. 2012
    ..Therefore, antifibrinolytic amino acids have been proposed to be used as supplementary interventions alongside any of the primary treatments for upper gastrointestinal bleeding in patients with liver diseases...
  9. doi request reprint Vitamin K for upper gastrointestinal bleeding in patients with acute or chronic liver diseases
    Arturo J Martí-Carvajal
    Facultad de Ciencias de la Salud Eugenio Espejo, Universidad Tecnológica Equinoccial, Quito, Ecuador
    Cochrane Database Syst Rev 9:CD004792. 2012
    ..One of them is vitamin K administration, but it is not known whether it benefits or harms patients with acute or chronic liver disease and upper gastrointestinal bleeding...
  10. doi request reprint Treatment for avascular necrosis of bone in people with sickle cell disease
    Arturo J Martí-Carvajal
    Universidad de Carabobo and Iberoamerican Cochrane Network, Valencia, Venezuela
    Cochrane Database Syst Rev 5:CD004344. 2012
    ..Avascular necrosis of bone is a frequent and severe complication of sickle cell disease and its treatment is not standardised...
  11. doi request reprint Human recombinant activated protein C for severe sepsis
    Arturo J Martí-Carvajal
    Universidad de Carabobo and Iberoamerican Cochrane Network, Valencia, Edo Carabobo, Venezuela
    Cochrane Database Syst Rev 3:CD004388. 2012
    ..Human recombinant activated protein C (APC) has been used to reduce the high rate of death by severe sepsis or septic shock. This is an update of a Cochrane review (originally published in 2007 and updated in 2008)...